€877.00
Delivery time: 1 to 2 weeks
Product number:
0720-1102
Product information "Seraseq® Antepartum 22q11 Male cfDNA"
Seraseq® Antepartum 22q11 Male cfDNA is a reference material for non-invasive prenatal testing (NIPT) of the 22q11 fetal microdeletion in pregnant patients via cell-free DNA (cfDNA) analysis. This product is derived from a naturally-occurring mixture of maternal and fetal circulating cell-free DNA in a pregnant donor’s prenatal blood sample whose male fetus has been diagnosed with a 22q11 microdeletion (DiGeorge Syndrome). The native cfDNA characteristics such as size profile of ~170 bp, SNP content and natural maternal-fetal size difference are preserved. This product is designed for use in NGS, PCR or microarray-based NIPT assays in steps that follow cfDNA isolation; and no further purification or DNA isolation is needed.
| Product type: | Control & reference materials |
|---|---|
| Regulatory status: | RUO |
| Content: | 1 x 25 µl |
| Storage temperature: | -20 °C |
| Shipping method: | Dry ice |
| Country of distribution: | Germany, Austria |